Per-Olof Bertil Gunnesson

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden.

Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden.